Global Daily Briefing

The 60-day negotiation window established by a June interim agreement between the US and Iran expired August 17 without a deal, with President Trump confirming no active negotiations. The breakdown is the proximate cause of the Treasury yield spike that hit global equities — higher oil prices (geopolitical risk premium), rising inflation expectations, and reduced Fed dovishness calculus compressed equity multiples globally. The Nasdaq fell 1.33% on August 18 (Korean sources); European stocks hit two-week lows; global bond yields reached multi-year highs. Until a diplomatic development breaks this loop, the geopolitical risk premium in oil and bonds stays structurally elevated.

The session's two standout global performers were Moderna (US/Canada, mRNA melanoma vaccine success) and Barrick Gold (Canada/global, safe-haven surge). Both represent the same macro bid: capital rotating away from rate-sensitive growth and toward either hard assets (gold) or near-term catalysts (drug approvals) that are insulated from the bond yield risk. The healthcare theme extended globally — GSK +3.4% in the UK, TMO +4.2% in the US — while gold miners dominated in Australia and Canada. This cross-region sectoral convergence on healthcare and gold is a classic late-cycle, high-uncertainty signature.

The most immediate binary for global markets heading into the weekend is the US-Canada trade deal deadline at 12:01am Saturday. Trump's 50% tariff threat is on pause but resumes if no deal is finalized. Canadian markets saw the Big Six banks sell off 3-4% on the uncertainty while gold (Barrick +8.8%) captured the safe-haven hedge. If Saturday passes without a deal, expect: CAD weakness, TSX bank continuation lower, and a Monday morning risk-off read for North American markets that could spread to Europe's Tuesday open. A deal removes all of that and triggers a sharp CAD + TSX bank rally.